Domov › Sladkorna bolezen tipa 2 › Florida

Klinične študije za Sladkorna bolezen tipa 2 v Florida

48 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v Florida.

Mesta v Florida

Uradno besedilo študije (angleško)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Orlando Health, St. Petersburg

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06906640

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Orlando Health, St. Petersburg

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06906627

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Omega Research Orlando, Altamonte Springs
American Research Institute, Cutler Bay
K2 Medical Research - Maitland, Maitland
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Northeast Research Institute, Fleming Island
AGA Clinical Trial, Hialeah
Adult Medicine of Lake County, Inc, Mt. Dora
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Excel Medical Clinical Trials, Boca Raton
Clinical Research of West Florida, Inc., Clearwater
Beautiful Minds Clinical Research Center, Cutler Bay
in še 32

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Clinical Research of West Florida, Inc., Clearwater
Northeast Research Institute, Fleming Island
Covenant Metabolic Specialists, LLC - Fort Myers, Fort Myers
in še 12

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461

A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Clinical Pharmacology of Miami, Miami
Progressive Medical Research, Port Orange

Vključevanje udeležencevFaza 1

Starost 18–65 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07223333

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Flourish Medical Research, Boca Raton
Apex Research, Cross City
Evolution Research Center, Hialeah
in še 12

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 55 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06112418

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Clinical Pharmacology of Miami, Miami

Vključevanje udeležencevFaza 1

Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nature Coast Clinical Research, Crystal River
West Coast Eye Institute, Lecanto
South Broward Research, Miramar
in še 3

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Jacksonville
Research Site, Jacksonville

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Arrow Clinical Trials, Daytona Beach
Care Access - Delray Beach, Delray Beach
Fleming Island Center for Clinical Research, Fleming Island
in še 7

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Coral Gables
Research Site, Fleming Island
Research Site, Fort Lauderdale
in še 1

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Boca Raton
AURORA-2 Clinical Site, Daytona Beach
AURORA-2 Clinical Site, Jacksonville
in še 6

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

AES - DRS - Optimal Research Florida - Melbourne, Melbourne
Tampa General Hospital, Tampa
Conquest Research LLC - Winter Park, Winter Park

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Tampa Bay Medical Research, Inc., Clearwater
Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
Progressive Medical Research, Port Orange
in še 1

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Renstar Medical Research, Ocala
Oviedo Medical Research, Oviedo

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Encore Medical Research LLC, Hollywood
Bioclinical Research Alliance, Miami
South Broward Research LLC, Miramar
in še 2

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

D&H Doral Research Center, Doral
AGA Clinical Trials, Hialeah
Convenient Medical Center, Hialeah
in še 13

Vključevanje udeležencevFaza 2

Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Encore Medical Research LLC, Hollywood
South Broward Research LLC, Miramar
Encore Medical Research of Weston, Weston

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site, Crystal River
Research Site, Hollywood
Research Site, Jacksonville
in še 3

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Velocity Clinical Research, New Smyrna Beach, Edgewater
The Center for Diabetes and Endocrine Care, Fort Lauderdale
Admed Research LLC, Miami
in še 4

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Encore Medical Research Boynton Beach, Boynton Beach
Nemours Chld Clnc Jacksonville, Jacksonville
Innovus Clinical, Kissimmee
in še 2

Vključevanje udeležencevFaza 3

Starost 10–18 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07282613

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Precision Clinical Research, Sunrise

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Optimus U Corporation, Miami
San Marcus Research Clinic Inc, Miami Lakes
Indago Research and Health Center, Miami Lakes
in še 3

Vključevanje udeležencevFaza 3

Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site, Fleming Island
Research Site, Lauderdale Lakes
Research Site, Leesburg
in še 3

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Innovative Research of W FL, Clearwater
Nature Coast Clin Rsrch_Crystal River, Crystal River
Florida Premier Cardiology, Delray Beach
in še 15

Vključevanje udeležencevFaza 3

Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Research Site, Lake City
Research Site, Lakeland

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662109

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Research Site, Jacksonville
Research Site, Orlando

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662044

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Research Site, Jacksonville
Research Site, Lake City
Research Site, Leesburg
in še 1

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07606066

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Accel Research Sites - DeLand, DeLand
Charter Research, Orlando
AdventHealth Translational Research Institute, Orlando
in še 1

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07527650

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

AdventHealth Translational Research Institute, Orlando

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 25–55 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06993454

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Nemours Children's Health, Jacksonville
D&H National Research Centers, Inc, Miami
AdventHealth Orlando, Orlando
in še 2

Vključevanje udeležencevFaza 3

Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Research Site, Doral
Research Site, Ocoee

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07664553

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Translational Clinical Research LLC, Aventura

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07590193

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Metabolic Research Institute, West Palm Beach

Vključevanje udeležencev

Starost 18–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07521475

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Southwest General Healthcare Center, Fort Myers
Panax Clinical Research, Miami Lakes
Flourish Research Orlando, Winter Park

Vključevanje udeležencevFaza 2

Starost 18–70 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07502508

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Johns Hopkins All Children's Hospital, St. Petersburg

Vključevanje udeležencevOpazovalna študija

Starost 8–15 · Vsi spoli · Posodobljeno 7. maj 2026 · NCT06525259

A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes

Clinical Pharmacology of Miami, Miami

Vključevanje udeležencevFaza 1

Starost 18–65 · Vsi spoli · Posodobljeno 6. maj 2026 · NCT07568678

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Universal Axon Clinical Research, Doral
Velocity Clinical Research New Smyrna Beach, Edgewater
Southwest General Healthcare Center, Fort Myers
in še 3

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT07546929

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.